Spravato Treatment (by ESKetamine) for Depression
Spravato is considered by many to be one of the biggest breakthroughs in depression treatment since the advent of Prozac. Spravato is the brand name for esketamine which is used in treating treatment-resistant depression and acute suicidal thinking.
Spravato is FDA-approved, prescribed by a psychiatrist or psychiatric nurse practitioner, and administered in a controlled environment. It is self-administered intranasally in the office under the care and supervision of an on-site registered nurse or trained technician. The effects of Spravato are felt within hours, compared to traditional depression medication which can take several weeks to months to take effect. Spravato can serve as a catalyst for therapeutic growth for many for whom more traditional mental health interventions have fallen short.